| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.211 | 0 | 5.863 | 4.787 | 19.167 | 243.827 | 225.571 | 140.542 | 209.733 | 213.234 |
| Total Income - EUR | 26.502 | 7.571 | 5.863 | 4.787 | 19.423 | 248.049 | 256.593 | 636.299 | 224.882 | 225.239 |
| Total Expenses - EUR | 7.607 | 1.179 | 3.495 | 2.614 | 22.647 | 244.369 | 238.978 | 234.255 | 213.036 | 217.412 |
| Gross Profit/Loss - EUR | 18.895 | 6.392 | 2.368 | 2.174 | -3.224 | 3.679 | 17.614 | 402.044 | 11.845 | 7.828 |
| Net Profit/Loss - EUR | 18.100 | 6.165 | 2.192 | 2.030 | -3.622 | 1.436 | 15.613 | 395.689 | 9.641 | 1.920 |
| Employees | 1 | 0 | 1 | 1 | 6 | 6 | 5 | 5 | 4 | 3 |
Check the financial reports for the company - Bioliv Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 48.098 | 46.046 | 43.986 | 49.816 | 48.386 | 39.122 | 321.003 | 305.069 | 310.423 |
| Current Assets | 696 | 1.743 | 5.507 | 9.090 | 74.455 | 110.512 | 138.287 | 258.119 | 246.001 | 241.351 |
| Inventories | 0 | 0 | 0 | 0 | 72.870 | 85.426 | 50.105 | 64.627 | 54.599 | 55.143 |
| Receivables | 117 | 116 | 1.427 | 1.401 | 109 | 12.234 | 13.545 | 23.606 | 7.942 | 4.699 |
| Cash | 579 | 1.627 | 4.080 | 7.689 | 1.476 | 12.853 | 74.637 | 169.886 | 183.460 | 181.509 |
| Shareholders Funds | -23.546 | -17.141 | -14.658 | -12.187 | -15.573 | -13.871 | 2.049 | 397.744 | 406.180 | 403.819 |
| Social Capital | 45 | 45 | 44 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 24.241 | 66.982 | 66.212 | 65.263 | 139.844 | 172.769 | 175.360 | 181.377 | 144.890 | 147.954 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4622 - 4622" | |||||||||
| CAEN Financial Year |
4622
|
|||||||||
Comments - Bioliv Srl